Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental and Molecular Pathology is Scopus-indexed (Q1, CiteScore 6.3), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme for reading access. Published by Academic Press Inc..
Checked against the index lists dated .
ISSN 0014-4800Verify ISSN ↗1096-0945Verify ISSN ↗
Publisher: Academic Press Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 29 / 209 | 86th | Q1 |
| Clinical Biochemistry | 40 / 124 | 68th | Q2 |
| Molecular Biology | 170 / 414 | 59th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1997–present (also 1962–1995), best quartile Q1, CiteScore 6.3.
Experimental and Molecular Pathology is Q1 in Pathology and Forensic Medicine (rank 29 of 209), Q2 in Clinical Biochemistry (rank 40 of 124) and Q2 in Molecular Biology (rank 170 of 414), by CiteScore 2025.
Experimental and Molecular Pathology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.3, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.109, quartile Q1, with an H-index of 84.
The publisher lists an article processing charge of about US$2,640 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Experimental and Molecular Pathology is published by Academic Press Inc. Its print ISSN is 0014-4800 and its online ISSN is 1096-0945.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Experimental and Molecular Pathology has an h-index of 113 and a 2-year mean of 3.74 citations per paper (OpenAlex). Its Scopus CiteScore is 6.3, quartile Q1. On 2-year citations it ranks #16 of 208 Scopus journals in Pathology and Forensic Medicine.
Experimental and Molecular Pathology published 65 papers in 2025; its busiest recent year was 2020 with 180. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from China (20.8%), United States (9.6%) and Japan (9.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 84 retracted papers are recorded (16.6 per 1,000 papers). The Problematic Paper Screener flags 4 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.